Recent study revealed that mitochondrially targeted metformin (MitoMet) considerably more efficiently killed pancreatic cancer cells and suppressed pancreatic tumors in vivo by targeting the mitochondrial complex I (CI) [48]. The gene discussed is NDUFB6; the disease is familial pancreatic carcinoma.